Hidoc Dr | Medical Learning App for Doctors

Today's Updates

AD109 Cuts AHI by 59.6% in Postmenopausal Women With OSA Reena Mehra, MD

Published Date: 07 Nov 2026

In a post hoc analysis of 2 phase 3 trials, AD109 reduced hypoxic burden by 69.8% vs 20.0% with placebo in postmenopausal women with OSA.

Mucus Plug Reduction with Type 2 Biologics: Lessons for COPD

Published Date: 07 Nov 2026

Mucus Plug Reduction with Type 2 Biologics: Lessons for COPD

2027 GOLD Report Update Preview: Changes in COPD Treatment, Biologics

Published Date: 07 Nov 2026

2027 GOLD Report Update Preview: Changes in COPD Treatment, Biologics

Q&A: Why IL-33 Matters for Mucus Plugs, Inflammation in COPD

Published Date: 07 Nov 2026

Q&A: Why IL-33 Matters for Mucus Plugs, Inflammation in COPD

Distinguishing Lambert-Eaton Myasthenic Syndrome From Ocular Myasthenia Gravis in the Eye Clinic Marco Meglio

Published Date: 07 Nov 2026

Kiril Kiprovski, MD, clinical professor of neurology and director of the Division of Neuromuscular Medicine at NYU Langone, reviews the clinical clues, bedside tests, and referral considerations that help eye care clinicians identify Lambert-Eaton myasthenic syndrome in patients with fluctuating ptosis or diplopia.

PREVAiLS Phase 3 Trial Evaluates Pridopidine in Early, Rapidly Progressive ALS Louie Pasculli

Published Date: 07 Nov 2026

The 500-participant study will assess whether pridopidine, an investigational sigma-1 receptor agonist, can slow functional decline and improve survival in patients with early, rapidly progressing amyotrophic lateral sclerosis.

Knowledge Hub

Oncology

Emerging Trends in Oncology and Precision Medicine

A clinical review of emerging oncology and precision medicine trends, including molecular diagnostics, targeted therapy, immunotherapy, liquid biopsy, and guideline-based care.

Oncology

Emerging Trends in Oncology and Precision Medicine

A clinical review of precision oncology, emerging therapies, molecular diagnostics, guideline-based care, and future directions in cancer medicine.

Oncology

Tumor-Associated Macrophage Iron Recycling and Its Influence on Local Antitumor Immune Activity

A medical review of how tumor-associated macrophage iron recycling shapes local antitumor immunity, tumor progression, biomarkers, and emerging therapies.

Oncology

Engineered Lymphoid Tissue Niches for Reconstructing Immune-Supportive Microenvironments After Cancer Treatment

A medical review of engineered lymphoid tissue niches for restoring immune function after cancer treatment, including mechanisms, clinical applications, risks, and emerging research.

Oncology

KOL Videos

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Your one-stop Solution for MEDICAL LEARNING & UPDATES

AD109 Cuts AHI by 59.6% in Postmenopausal Women With OSA Reena Mehra, MD

Mucus Plug Reduction with Type 2 Biologics: Lessons for COPD

2027 GOLD Report Update Preview: Changes in COPD Treatment, Biologics

Q&A: Why IL-33 Matters for Mucus Plugs, Inflammation in COPD

Distinguishing Lambert-Eaton Myasthenic Syndrome From Ocular Myasthenia Gravis in the Eye Clinic Marco Meglio

PREVAiLS Phase 3 Trial Evaluates Pridopidine in Early, Rapidly Progressive ALS Louie Pasculli

Knowledge Hub

Emerging Trends in Oncology and Precision Medicine

Emerging Trends in Oncology and Precision Medicine

Tumor-Associated Macrophage Iron Recycling and Its Influence on Local Antitumor Immune Activity

Engineered Lymphoid Tissue Niches for Reconstructing Immune-Supportive Microenvironments After Cancer Treatment

Monitoring Delayed Toxicities of Cellular Cancer Therapies

Genomic Determinants of Tumor Cell Dormancy in Minimal Residual Cancer Disease

Therapeutic Advances in Tumor Nutrient-Deprivation Strategies

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Page Views

Your one-stop Solution for MEDICAL LEARNING & UPDATES

AD109 Cuts AHI by 59.6% in Postmenopausal Women With OSA Reena Mehra, MD

Mucus Plug Reduction with Type 2 Biologics: Lessons for COPD

2027 GOLD Report Update Preview: Changes in COPD Treatment, Biologics

Q&A: Why IL-33 Matters for Mucus Plugs, Inflammation in COPD

Distinguishing Lambert-Eaton Myasthenic Syndrome From Ocular Myasthenia Gravis in the Eye Clinic Marco Meglio

PREVAiLS Phase 3 Trial Evaluates Pridopidine in Early, Rapidly Progressive ALS Louie Pasculli

Knowledge Hub

Emerging Trends in Oncology and Precision Medicine

Emerging Trends in Oncology and Precision Medicine

Tumor-Associated Macrophage Iron Recycling and Its Influence on Local Antitumor Immune Activity

Engineered Lymphoid Tissue Niches for Reconstructing Immune-Supportive Microenvironments After Cancer Treatment

Monitoring Delayed Toxicities of Cellular Cancer Therapies

Genomic Determinants of Tumor Cell Dormancy in Minimal Residual Cancer Disease

Therapeutic Advances in Tumor Nutrient-Deprivation Strategies

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Verification

Welcome to Hidoc Dr.

Page Views